Nick talks to Dr. Berra Yazar-Klosinski, the Chief Science Officer for the Multidisciplinary Assocation for Psychedelic Studies (MAPS). Berra talked about the results of MAPS’ recent Phase III clinical trials for treating severe PTSD, how these studies are conducted, and what we know about the underlying biology of Post-Traumatic Stress Disorder (PTSD) and the drug MDMA.
Donate to MAPS: https://maps.org/donate
Support the podcast: https://www.patreon.com/goodchemistry
Full audio episodes (higher quality): nickjikomes.com
Join the community (use promo code ‘greatchem’): https://goodchemistry.locals.com/